Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Receivables (2023 - 2025)

Historic Receivables for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $515000.0.

  • CG Oncology's Receivables rose 27591.24% to $515000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $515000.0, marking a year-over-year increase of 27591.24%. This contributed to the annual value of $92000.0 for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, CG Oncology's Receivables is $515000.0, which was up 27591.24% from $562000.0 recorded in Q2 2025.
  • Over the past 5 years, CG Oncology's Receivables peaked at $562000.0 during Q2 2025, and registered a low of $92000.0 during Q4 2023.
  • Moreover, its 3-year median value for Receivables was $182000.0 (2024), whereas its average is $283714.3.
  • Examining YoY changes over the last 5 years, CG Oncology's Receivables showed a top increase of 27591.24% in 2025 and a maximum decrease of 12549.02% in 2025.
  • Quarter analysis of 3 years shows CG Oncology's Receivables stood at $92000.0 in 2023, then skyrocketed by 48.91% to $137000.0 in 2024, then soared by 275.91% to $515000.0 in 2025.
  • Its Receivables stands at $515000.0 for Q3 2025, versus $562000.0 for Q2 2025 and $345000.0 for Q1 2025.